American Heart Association Calls for Action on Teen Vaping

Jun.22.2022
American Heart Association Calls for Action on Teen Vaping
The American Heart Association warns decision-makers to act in order to reduce or prevent teenage e-cigarette usage.

A new scientific statement issued by the American Heart Association is calling on decision-makers at the local, state, and national levels to take action to reduce or prevent youth use of e-cigarettes in order to lower their risk of developing lifelong cardiovascular disease.

 

According to a statement led by Dr. Loren Wold, a professor and associate dean responsible for research, operations, and compliance at Ohio State University's College of Medicine, current scientific evidence suggests that e-cigarettes may have negative effects on users' cardiovascular and respiratory systems.

 

Since electronic cigarettes were introduced to the US market at the beginning of the 21st century, they have become a popular trend, especially among teenagers. This has reversed the decreasing trend in tobacco use among young people and has also resulted in a decrease in nicotine dependency among users of combustible cigarettes. According to a statement published online today in the journal Circulation Research, young people who start smoking now may become lifelong tobacco or nicotine users.

 

Dr. Lauren Walden stated that most research on the use of electronic cigarettes has been conducted on adults or animals. It is crucial to understand how the organ systems of young e-cigarette users are affected, especially the long-term impact into adulthood. Dr. Walden's recent study on mice revealed that smoking has significant long-term effects on cardiovascular health in adolescent males that persist into adulthood.

 

According to the statement, there is still a lot unknown about the toxicity of electronic cigarettes, partly due to many manufacturers not disclosing a full list of ingredients. Without knowledge of the exact composition of the products within these devices, it is difficult to predict or determine the health impact on the lungs and heart. Besides nicotine or tetrahydrocannabinol, electronic liquid also contains vegetable glycerin and propylene glycol, both of which are considered safe by the US Food and Drug Administration. However, these compounds are not intended for inhalation and have not been tested for their effects on users when inhaled. When heated, these compounds often break down into other chemicals such as formaldehyde, a known carcinogen.

 

Inhaling any foreign substance can have an impact on the respiratory and cardiovascular systems," said Wald, who is also the Assistant Dean of Biological Health Research at the nursing school.

 

Furthermore, an individual's lung development continues into their early 20s, which means that teenagers who use drugs may experience delayed or altered lung development, which can result in an inability to achieve full lung function.

 

Previous research has found that using electronic cigarettes increases the risk of respiratory health problems, including wheezing, coughing, asthma, and lung infections. Furthermore, studies have also found that young adults who use electronic cigarettes experience arterial stiffness, impaired vascular function, and elevated blood pressure and heart rate. This evidence suggests that long-term electronic cigarette use may lead to the development of cardiovascular diseases.

 

While teenagers who use e-cigarettes may not currently think that smoking is affecting them, it is becoming increasingly clear that the chemicals found in e-cigarette aerosols are damaging cardiovascular cells, leading to long-term changes that facilitate the development of heart disease, "says Walde. "People who smoke combustible cigarettes usually take decades to develop cardiovascular disease and/or chronic obstructive pulmonary disease. The same may be true for e-cigarette users. Reducing the smoking rates among teenagers may help improve their long-term cardiopulmonary function.

 

A new study has found that many people who use electronic cigarettes as an aid to stop smoking combustible cigarettes end up using both products regularly. The study emphasizes the importance of distinguishing between tobacco cessation and nicotine cessation. An investigation conducted in the UK discovered that e-cigarettes contain significantly less nicotine than in the US. In terms of giving up combustible tobacco cigarettes, e-cigarettes may be more effective than nicotine patches (18% vs 10%). However, the study found that e-cigarettes were four times less successful at reducing nicotine consumption (20% for e-cigarettes compared to 81% for nicotine patches).

 

The customizability of vaping, including power levels, e-liquid content, and a variety of flavors, has attracted young people, making regulation of these products difficult, according to Walda. While the FDA has released a policy opposing e-liquid flavors like mint and fruit that are known to attract young people, there are still mint-flavored products on the market for certain product types. Additionally, the US does not have regulatory standards limiting the nicotine concentration in e-liquids, and some devices have been found to contain as much as 59 milligrams per milliliter. In contrast, the EU limits nicotine concentrations in e-liquids to below 20 milligrams per milliliter, which is similar to the concentration in standard combustible cigarettes.

 

The statement suggests taking measures to clear all flavored e-cigarettes, including mint-flavored ones, from the market. Other public health and policy recommendations are also included.

 

Implement better measures to reduce the access of electronic cigarettes for teenagers, including strict age verification in sales venues and banning marketing of e-cigarettes targeted towards teenagers.

 

Provide more education for teenagers and their parents regarding the use of e-cigarettes and their potential health risks.

 

A course on electronic cigarettes is being introduced for medical students to provide information to the next generation of healthcare professionals.

 

Ensure the provision of hospital-based smoking cessation programs for both adolescents and adults.

 

Regulating the marketing of electronic cigarettes on traditional, online, and social media platforms that are popular among young people.

 

Include electronic cigarettes in smoke-free air policies.

 

Source: Wexner Medical Center

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Iowa Vape Directory Exposes Retail Divide: Specialty Vape Retailer Route 69 Vapor Says Over 98% of Its Inventory Is Unlisted, While Convenience Chains Casey’s, Maverik and Tobacco Giant Altria Previously Backed the Law
Iowa Vape Directory Exposes Retail Divide: Specialty Vape Retailer Route 69 Vapor Says Over 98% of Its Inventory Is Unlisted, While Convenience Chains Casey’s, Maverik and Tobacco Giant Altria Previously Backed the Law
Iowa published its first vapor products directory on November 16, 2026, restricting retail sales to products covered by 361 listed entries. In interviews published on November 18, independent vape retailers described inventory restrictions, revenue exposure and store closure plans. Route 69 Vapor said more than 98% of its inventory was excluded from the directory, while Central Iowa Vapors said approximately 91% of its existing product assortment was unlisted. A mixed tobacco retailer reported nearly $15,000 in vape inventory that suppliers would not accept for return. Iowa legislative records show that convenience store and fuel retail chains Casey’s and Maverik, along with tobacco company Altria, supported the legislation establishing the directory in 2024. The new rules also affect licensed distributors, wholesalers and manufacturers, bringing supply-chain arrangements into the dispute over retail access.
Regulations
Nov.19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Philip Morris Japan (PMJ) launched TEREA Black Mint Pearl on October 15, 2026, introducing the first capsule-equipped heated tobacco stick in the TEREA Black range for IQOS ILUMA devices. The product combines a strong menthol profile with a crushable mint capsule and is priced at ¥640 per 20-stick pack, including tax. Sales began at four IQOS stores and selected retail partners on October 15, with distribution expanding to convenience stores and other tobacco retailers nationwide from October 19. The launch brings Japan's TEREA portfolio to 28 variants, including 21 menthol-related products, or 75% of the range.
product
Oct.16 by 2Firsts Perspectives
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Philip Morris International (PMI) introduced TEREA Bold Red and Bold Black heated tobacco sticks in Germany in October 2026, both carrying a brand-rated tobacco-flavor intensity of 10, the highest level in the country's TEREA portfolio. Bold Red features leather and warm woody notes, while Bold Black combines woody and subtle floral notes. Both are sold in 20-stick packs at €8, approximately 2.6% above standard TEREA products. Germany's TEREA range now includes 11 flavor variants, alongside a separate 26-stick XL format priced at €10. IQOS Germany announced the new products on October 12, followed by a phased retail rollout from late October and an IQOS Club campaign running through December.
product
Nov.02
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Product | JT Launches Three Autumn-Limited Ploom Tobacco Sticks in Japan Across EVO, MEVIUS and CAMEL Brands
Japan Tobacco Inc. (JT) launched three limited-edition autumn tobacco sticks for its Ploom heated tobacco devices in Japan on October 16, 2026, under the EVO, MEVIUS and CAMEL brands. All three are regular tobacco variants with seasonal packaging. Each pack contains 20 sticks, priced at ¥620, ¥590 and ¥570, respectively, including tax. The products are compatible with all Ploom devices and are sold in limited quantities exclusively through the CLUB JT online store while supplies last.
product
Oct.20
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China's vape-related exports rose 4.5% year over year to $2.86 billion in the third quarter of 2026, led by stronger shipments to the United Kingdom as exports to the United States declined. UK-bound shipments increased 21.6%, adding $81.9 million, while US exports fell 5.2%, or $53.6 million. Growth weakened through the quarter, with September exports down 6.3% globally and 37.8% to the US. Nicotine-containing vape products accounted for more than 82% of the quarterly net increase, while device exports were nearly flat. Nine-month exports totaled $7.82 billion, up 4.0%.
DATA
Oct.26
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03